On these grounds, the present study aimed at exploring the possible correlation of KIR/HLA haplotypes with the induction of a pCR after NC in a cohort of patients affected by locally advanced BC overexpressing HER2 and treated with trastuzumab. The gene discussed is KIR3DL1; the disease is breast cancer.